Physician profile
Randall Higashida
NPI 1902882046
$21,768.80
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $171 · 2020: $71.03 · 2021: $378 · 2022: $11K · 2023: $9,607 · 2024: $73.39.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,416 · Consulting Fee: $4,350 · Food and Beverage: $914.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,415.94 |
| Consulting Fee | $4,350.00 |
| Food and Beverage | $914.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Idorsia Pharmaceuticals US INC | $19,547.95 | 2022-2023 | Clazosentan |
| Stryker Corporation | $1,829.43 | 2019-2024 | Neuroform Atlas, Target, Axs Catalyst 7 |
| Microvention, INC. | $91.17 | 2019-2020 | |
| Penumbra, INC. | $77.40 | 2019-2021 | |
| Abbott Laboratories | $60.99 | 2020-2021 | |
| Cardiva Medical, INC. | $54.74 | 2022 | |
| Imperative Care, INC | $45.66 | 2022 | |
| Medtronic, INC. | $40.10 | 2023 | Rist |
| Medtronic USA, INC. | $21.36 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Randall Higashida listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.